Dowers Kristy L, Uhrig Samantha R, Mama Khursheed R, Gaynor James S, Hellyer Peter W
Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1601, USA.
Am J Vet Res. 2006 Oct;67(10):1794-801. doi: 10.2460/ajvr.67.10.1794.
To evaluate effects of injection with a nonsteroidal anti-inflammatory drug (NSAID) followed by oral administration of an NSAID on the gastrointestinal tract (GIT) of healthy dogs.
6 healthy Walker Hounds.
In a randomized, crossover design, dogs were administered 4 treatments consisting of an SC injection of an NSAID or control solution (day 0), followed by oral administration of an NSAID or inert substance for 4 days (days 1 through 4). Treatment regimens included carprofen (4 mg/kg) followed by inert substance; saline (0.9% NaCl) solution followed by deracoxib (4 mg/kg); carprofen (4 mg/kg) followed by carprofen (4 mg/kg); and carprofen (4 mg/kg) followed by deracoxib (4 mg/kg). Hematologic, serum biochemical, and fecal evaluations were conducted weekly, and clinical scores were obtained daily. Endoscopy of the GIT was performed before and on days 1, 2, and 5 for each treatment. Lesions were scored by use of a 6-point scale.
No significant differences existed for clinical data, clinicopathologic data, or lesion scores in the esophagus, cardia, or duodenum. For the gastric fundus, antrum, and lesser curvature, an effect of time was observed for all treatments, with lesions worsening from before to day 2 of treatments but improving by day 5.
Sequential administration of NSAIDs in this experiment did not result in clinically important gastroduodenal ulcers. A larger study to investigate the effect of sequential administration of NSAIDs for longer durations and in dogs with signs of acute and chronic pain is essential to substantiate these findings.
评估先注射一种非甾体抗炎药(NSAID)随后口服另一种NSAID对健康犬胃肠道(GIT)的影响。
6只健康的沃克猎犬。
采用随机交叉设计,给犬只进行4种处理,包括皮下注射一种NSAID或对照溶液(第0天),随后口服一种NSAID或惰性物质,持续4天(第1天至第4天)。处理方案包括:卡洛芬(4毫克/千克)后接惰性物质;生理盐水(0.9%氯化钠)溶液后接德拉考昔(4毫克/千克);卡洛芬(4毫克/千克)后接卡洛芬(4毫克/千克);卡洛芬(4毫克/千克)后接德拉考昔(4毫克/千克)。每周进行血液学、血清生化和粪便评估,每天获取临床评分。每种处理在第1、2和5天以及处理前对GIT进行内镜检查。病变采用6分制评分。
食管、贲门或十二指肠的临床数据、临床病理数据或病变评分无显著差异。对于胃底、胃窦和胃小弯,所有处理均观察到时间效应,病变从处理前到第2天恶化,但到第5天有所改善。
本实验中NSAIDs的序贯给药未导致具有临床意义的胃十二指肠溃疡。开展一项更大规模的研究,以调查NSAIDs序贯给药更长时间以及对有急慢性疼痛体征犬只的影响,对于证实这些发现至关重要。